Navigation Links
International Study Confirms CNSystems-Technology
Date:9/30/2011

GRAZ, Austria, September 30, 2011 /PRNewswire/ --

The well-established high tech company CNSystems once again attracts international attention with a big mile stone. The Bordeaux University Hospital (France) confirms that the validated CNAP blood pressure wave offers the possibility of precise therapy control during surgery. Already today, the recently released product innovation CNAP-PPV, proves to be a sensational, noninvasive alternative solution to the standard high-risk procedures for monitoring the fluid status during operations.

CNAP-PPV is the noninvasive solution for the continuous monitoring of the patient's fluid status during surgery. With a simple double-finger cuff CNAP-PPV and, simultaneously, the blood pressure are measured for every single heartbeat.

This ingenious combination monitors blood pressure and fluid status without burdening the patient's body with risky, invasive procedures always requiring an arterial catheter.

The French team of Univ.-Prof. Matthieu Biais confirms in its scientific publication that the CNAP-PPV method perfectly shows the same outcome as the expensive and high-risk invasive procedures: "Our results suggest that in the operating room during vascular surgery, respiratory induced variations in the pulse pressure (PPV) measured non-invasively in the finger using the CNAP system correlate closely with the PPV measured invasively with an arterial catheter."

This brand new study emphasizes that the validated CNAP blood pressure wave allows for an accurate hemodynamic monitoring during operations. The increasing demand for risk-free and cost-saving solutions argue in favor of CNAP-PPV: "It is scientifically proven that fluid-optimization not only reduces patient risk but also shortens the duration of hospitalization.", says CNSystems-founder Dr. Juergen Fortin.

More than 86% of all US and 98% of all European intensive care specialists and anesthesiologists claim for improvements of hemodynamic monitoring as current technologies are not suitable for the full integration into the daily clinical routine.

The cost for CNAP-PPV only makes one-fifth compared to invasive methods. "This allows fluid-management to become a clinical standard in Anesthesia and can also be applied for minor-risk procedures.", explains Fortin.

Source:

Biais, M. et al. (2011). TheAbilityOfPulsePressureVariationsObtainedWithCNAP[TM]DeviceToPredictFluidResponsivenessInTheOperatingRoom. Anesthesia&Analgesia, 113(3), 523-8.

CNSystems from Austria is technological leader in noninvasive, continuous blood pressure measurement.

Contact:
Alice Wellisch
CNSystems Medizintechnik AG
Tel: +43-316-723456-0
E-Mail:office@cnsystems.at
http://www.cnsystems.at

 


'/>"/>
SOURCE CNSystems Medizintechnik AG
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
2. Yongye Biotechnology International Retains CCG Investor Relations
3. Huifeng Bio-Pharmaceutical (HFGB) Announces USD $1.1 Million Supply Agreement with DNP International Co. Inc.
4. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
5. Yongye Biotechnology International Announces Second Quarter Results
6. Medizone International, Inc. Appoints Dr. Michael E. Shannon to Its Board of Directors
7. Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration
8. PAREXEL International To Present at Thomas Weisel Partners Healthcare Conference
9. Mindray Medical International Announces Second Quarter 2008 Results
10. Singapore to hold international pow-wow
11. Sangui BioTech International, Inc. Files Remaining Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 /PRNewswire/ ... London (ICR) and University of ... tool to risk-stratify patients with multiple myeloma (MM), in a ... . The University of Leeds is ... Myeloma UK, and ICR will perform the testing services to ...
(Date:10/10/2017)... CA (PRWEB) , ... October ... ... a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today ... of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... and business process optimization firm for the life sciences and healthcare industries, announces ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud ...
(Date:10/9/2017)... , ... October 09, 2017 , ... ... four-tiered line of medical marijuana products targeting the needs of consumers who are ... of Kindred takes place in Phoenix, Arizona. , As operators of two successful ...
Breaking Biology Technology:
(Date:4/5/2017)... -- KEY FINDINGS The global market for ... of 25.76% during the forecast period of 2017-2025. The ... the growth of the stem cell market. ... INSIGHTS The global stem cell market is segmented on ... stem cell market of the product is segmented into ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
(Date:3/24/2017)... DUBLIN , Mar 24, 2017 Research ... Vehicle Access System Market Analysis & Trends - Industry Forecast to ... ... poised to grow at a CAGR of around 15.1% over the ... This industry report analyzes the market estimates and forecasts for ...
Breaking Biology News(10 mins):